Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:8687 |
| Name | skin carcinoma in situ |
| Definition | A carcinoma in situ that is characterized by the spread of cancer in skin and the lack of invasion of surrounding tissues. |
| Source | DiseaseOntology.org |
| Alt Ids | DOID:9000 DOID:8989 DOID:8817 DOID:8686 DOID:8880 DOID:8699 DOID:9185 DOID:8831 DOID:9221 |
| Xrefs |
ICD10CM:D04 |
ICD10CM:D04.0 |
ICD10CM:D04.2 |
ICD10CM:D04.3 |
ICD10CM:D04.4 |
ICD10CM:D04.6 |
ICD10CM:D04.7
ICD9CM:232 |
ICD9CM:232.0 |
ICD9CM:232.2 |
ICD9CM:232.3 |
ICD9CM:232.4 |
ICD9CM:232.5 |
ICD9CM:232.6 |
ICD9CM:232.7
SNOMEDCT_US_2023_03_01:189276007 |
SNOMEDCT_US_2023_03_01:189291009 |
SNOMEDCT_US_2023_03_01:189295000 |
SNOMEDCT_US_2023_03_01:190179004 |
SNOMEDCT_US_2023_03_01:255144005 |
SNOMEDCT_US_2023_03_01:92735004 |
SNOMEDCT_US_2023_03_01:92747005 |
SNOMEDCT_US_2023_03_01:92749008
|
| Path | disease disease of cellular proliferation pre-malignant neoplasm in situ carcinoma skin carcinoma in situ |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04844983 | Phase II | Cotsiranib | A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC | Completed | USA | 0 |
| NCT06409195 | Phase II | SM-020 | A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers | Recruiting | USA | 0 |